Related Experiment Video

Updated: Aug 11, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Thrombolytic therapy for acute myocardial infarction: a brief review

J W Kennedy1

  • 1Department of Medicine, University of Washington School of Medicine, Seattle.

Heart & Lung : the Journal of Critical Care
|November 1, 1987
PubMed

Insights

Early thrombolytic therapy for acute myocardial infarction (MI) reduces mortality and preserves heart function. Ongoing research explores new agents like tissue-type plasminogen activator (t-PA) and prehospital interventions to further improve outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute myocardial infarction (MI) poses significant mortality risks.
  • Timely intervention is crucial for preserving myocardial function and reducing mortality.

Purpose of the Study:

  • To evaluate the efficacy of early thrombolytic therapy in reducing mortality and improving left ventricular function in acute MI patients.
  • To assess the potential benefits of newer thrombolytic agents and adjunctive therapies.
  • To explore the feasibility and impact of prehospital thrombolytic therapy.

Main Methods:

  • Review of existing data on thrombolytic therapy within 4-6 hours of evolving acute MI.
  • Evaluation of tissue-type plasminogen activator (t-PA) in multicenter trials.
  • Comparison of early versus delayed coronary artery angioplasty.
  • Assessment of adjunctive beta-blocker therapy.
  • Planning for studies on prehospital thrombolytic therapy.

Main Results:

  • Thrombolytic therapy within the first 4-6 hours appears to reduce in-hospital and 1-year mortality rates.
  • Early treatment may improve residual left ventricular function by preserving ischemic myocardium.
  • Newer agents like t-PA show promise for more effective thrombolysis.

Conclusions:

  • Early thrombolytic therapy is beneficial for acute MI patients.
  • Further research into advanced thrombolytic agents and prehospital administration holds potential for substantial mortality reduction.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...